Semaglutide in CFRD

Clinical trial NCT05788965 · COMPLETED

Trial details

NCT number: NCT05788965
Sponsor: University of Minnesota
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis Cystic Fibrosis-related Diabetes

Start date: 2023-10-16
Primary completion: 2024-12-23
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.